Literature DB >> 18053024

Injection site reactions to TNF-alpha blocking agents with positive skin tests.

M Benucci1, M Manfredi, P Demoly, P Campi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18053024     DOI： 10.1111/j.1398-9995.2007.01536.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  8 in total

1.  Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis.

Authors:  Birgit Sadoghi; Birger Kränke; Lorenzo Cerroni; Wolfgang Weger
Journal:  Acta Derm Venereol       Date:  2021-11-17       Impact factor: 3.875

Review 2.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

3.  Spondylarthritis presenting with an allergic immediate systemic reaction to adalimumab in a woman: a case report.

Authors:  Maurizio Benucci; Mariangela Manfredi; Sergio Testi; Maria L Iorno; Maurizio Valentini; Francesca Soldaini; Paolo Campi
Journal:  J Med Case Rep       Date:  2011-04-19

4.  Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent.

Authors:  Fevzi Demirel; Ozgur Kartal; Mustafa Gulec; Sait Yesillik; Abdullah Baysan; Kutay Tezel; Ugur Musabak; Osman Sener
Journal:  Drug Saf Case Rep       Date:  2015-12

5.  Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa.

Authors:  Farida Benhadou; Guillaume Hellgren; Fabienne Willaert; Véronique Del Marmol
Journal:  Case Rep Dermatol       Date:  2018-01-31

6.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

7.  Skin testing and patch testing in non-IgE-mediated drug allergy.

Authors:  Annick Barbaud
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.919

8.  Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction.

Authors:  Satoshi Nakamizo; Yoshiki Miyachi; Kenji Kabashima
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.